home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Skin Toxicology-Part 6: Testing for Photo-toxicity

 
  April 15, 2013  
     
 
CfPA - The Center for Professional Advancement, 90 Minute Accredited Online Training
June 17 2013 at 11:00 a.m.–12:30 p.m. (ET)


Who Should Attend
Professionals in the cosmetic and personal care or related industries that work and specialize in the following disciplines, as well as groups or companies that provide services in personal care in the following fields:

  • Research and Development 
  • Regulatory Affairs 
  • Safety Assessment 
  • Product Development 
  • Formulations Development

Description
Varieties of compounds that are incorporated into topical formulations and applied to skin are likely to absorb either UV or visible light when used in day time. These can potentially cause photo-toxicity reaction. Photo-toxicity reaction, irritating or sensitizating in nature occurs only when the potentially toxic compound is exposed to light and will not occur in the dark. While photo-irritation does not involve the acquired immune system, photo-allergy requires the recruitment of humoral immune system and builds long lasting memory markers in the individual’s body.

This 90-minute accredited training is focused on the definingis focused on the defining the different photo-toxicity reactions, understanding of current available methodologies to test for such, their scope, advantages and limitations.

 
 
Organized by: CfPA - The Center for Professional Advancement
Invited Speakers: Nava Dayan Ph.D., President, Dr. Nava Dayan LLC

Dr. Nava Dayan is an independent consultant offering a wide range of services for the Pharmaceutical, Cosmetic, Personal Care, Research Entities, Regulatory and Government Agencies and other organizations and institutions that are interested in skin health and science. A skin care and health expert, Dr. Dayan has over 24 years of experience in a variety of skin research and development schemes in the Personal Care, Cosmetics, Pharmaceutical, Medical Devices and Delivery System Industries. Expertise include product innovation, skin biochemistry, development of ingredients and formulations, skin delivery and delivery systems for dermal and transdermal applications, prevention of adverse effects, safety assessment (skin toxicology; in vitro methodologies), claim substantiation via clinical study design, execution and data interpretation.

Dr. Dayan’s major strengths and interests include: skin aging, skin inflammatory disorders, delivery systems for enlargement of therapeutic index, natural ingredients and formulations, skin’s innate immunity and barrier integrity, biochemical paths analysis, gene expression, skin research of toxicological endpoint and their assessment.
 
Deadline for Abstracts: n/a
 
Registration: Please click here for registration information.
E-mail: sberg@cfpa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.